Warmly welcome Vice Mayor Lin Keqing to visit Dongfang Baitai
- Categories:Company News
- Author:
- Origin:Dongfang Baitai
- Time of issue:2022-05-20
- Views:954
(Summary description)On October 24, 2016, a delegation led by Lin Keqing, Vice Mayor of Beijing, visited Beijing Orient Biotech Co., Ltd. and Biotech Pharmaceutical Co., Ltd. They conducted in-depth research on the R&D progress of the enterprise, visited the production workshop of the company on the spot, and had a cordial exchange.
Warmly welcome Vice Mayor Lin Keqing to visit Dongfang Baitai
(Summary description)On October 24, 2016, a delegation led by Lin Keqing, Vice Mayor of Beijing, visited Beijing Orient Biotech Co., Ltd. and Biotech Pharmaceutical Co., Ltd. They conducted in-depth research on the R&D progress of the enterprise, visited the production workshop of the company on the spot, and had a cordial exchange.
- Categories:Company News
- Author:
- Origin:Dongfang Baitai
- Time of issue:2022-05-20
- Views:954
On October 24, 2016, a delegation led by Lin Keqing, Vice Mayor of Beijing, visited Beijing Orient Biotech Co., Ltd. and Biotech Pharmaceutical Co., Ltd. They conducted in-depth research on the R&D progress of the enterprise, visited the production workshop of the company on the spot, and had a cordial exchange.
Mao Yu, director of the Municipal Health and Family Planning Commission, Cong Luoluo, director of the Municipal Food and Drug Administration, Xu Xi, director of the Municipal Bureau of Human Resources and Social Security, Yu Luming, director of the Municipal Medical Administration, and other municipal leaders accompanied the survey. There are also district leaders such as Tan Xuxiang, secretary of Daxing District Party Committee, Liang Sheng, director of Yizhuang Economic and Technological Development Zone, Wang Hesheng, executive deputy director, and Shen Yonggang, deputy director.
The leaders of the investigation team visited Dongfang Baitai and Baitai Bio on the spot, went deep into the front line of the workshop, and learned about the production and operation of the enterprise and the reserve of scientific and technological personnel in detail. Bai Xianhong, Chairman of Dongfang Baitai and Baitai Bio, reported to the leaders of the research team on the enterprise's R&D pipeline layout, production line construction and product sales, and made a key introduction to Taixinsheng.
Baitai Biological Pharmaceutical Co., Ltd. has tried the clinical application of monoclonal antibody drugs in the field of cancer treatment since 1999. In April 2008, Taixinsheng (Nitozumab) was officially listed as a humanized monoclonal antibody targeting EGFR.
Taixinsheng is a humanized monoclonal antibody targeting drug with high level of technology, precise targeting, safe use and significant efficacy. It has good therapeutic effect on head and neck tumors, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, glioma, non-small cell lung cancer and other cancers. To a certain extent, it has extended the life cycle of cancer patients, improved the quality of life of cancer patients, and cured many cancer patients.
Vice Mayor Lin Keqing congratulated Baitai Pharmaceutical on its rapid development. He was gratified by Dongfang Baitai's contribution to the people's health. At the same time, Vice Mayor Lin said that "if enterprises encounter difficulties in the development process, they should seek help from the government in a timely manner. The government will try its best to coordinate and solve problems and help enterprises solve problems". The scene was thunderous with applause. All the staff expressed their gratitude for the Mayor's support and were deeply encouraged!
The leaders of the research team agreed that as a class 1 biological new drug, Taixinsheng will benefit a large number of patients in China. Under the guidance and support of the government, enterprises should strive to realize the incorporation of drugs into the national medical insurance directory as soon as possible. It can enable more cancer patients to enjoy the high-quality results brought by scientific and technological progress.
The municipal leaders emphasized that all relevant departments should optimize the business environment of enterprises and enhance their support according to the deployment and requirements of the municipal party committee and the municipal government. They will encourage enterprises to innovate in science and technology, give more help in terms of policies and give more benefits in terms of support. They will effectively reduce the production cost of the enterprise, actively perform their duties and services, and solve the relevant problems reflected by the enterprise.
The company will live up to the care and expectations of all leaders and continue to be based on the life and health of Chinese people according to the relevant instructions of Vice Mayor Lin Keqing. We will speed up the process of new products coming into the market, make contributions to the creation of "Chinese brand" drugs, and make constant efforts to benefit the people!
Scan the QR code to read on your phone
推荐新闻
Follow us

Follow the official WeChat official account
Or search "Oriental Baitai"
More exciting waiting for you!
Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com
Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd SEO 京ICP备********号